Treating tobacco dependence in a medical setting.
The US Public Health Service Guideline for Treating Tobacco Use and Dependence 2008 Update emphasizes tobacco use as a chronic medical disorder; highlights both behavioral counseling and the use of 1 or more of the 7 approved medications; and points out the utility, efficacy, and reach of telephone quitlines. The treatment of users of smokeless tobacco continues to be less than optimal. Although providing evidence-based treatment for tobacco- dependent patients is a challenge for busy physicians, a team approach including trained and certified tobacco treatment specialists (TTS) provides an efficient treatment model. TTS represent a new and growing part of the health care team and hold great potential for expanding the collective tobacco treatment expertise in the medical setting. The effective treatment of tobacco dependence frequently requires tailoring, and often intensifying, interventions (both counseling and pharmacotherapy) to meet the needs of the individual patient.
Hurt
Richard D
RD
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA. rhurt@mayo.edu
Ebbert
Jon O
JO
Hays
J Taylor
JT
McFadden
David D
DD
D000818:Animals; D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D003367:Cotinine / Q000097:blood; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011810:Quinoxalines / Q000627:therapeutic use; D011978:Receptors, Nicotinic / Q000187:drug effects; D016540:Smoking Cessation / Q000379:methods; D020340:Tobacco Use Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D014481:United States; D014492:United States Public Health Service; D000068580:Varenicline
D001552:Benzazepines; D018765:Dopamine Uptake Inhibitors; D011810:Quinoxalines; D011978:Receptors, Nicotinic; D016642:Bupropion; D009538:Nicotine; D003367:Cotinine; D000068580:Varenicline
Nicotine Tob Res. 1999 Jun;1(2):169-74
11072398
N Engl J Med. 1999 Mar 4;340(9):685-91
10053177
JAMA. 2006 Jul 5;296(1):64-71
16820548
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
2899326
Clin Chem. 2002 Sep;48(9):1460-71
12194923
Clin Pharmacol Ther. 2001 Jun;69(6):438-44
11406741
Ann Intern Med. 2001 Sep 18;135(6):423-33
11560455
Eur Heart J. 2003 May;24(10):946-55
12714026
Psychopharmacology (Berl). 1995 Dec;122(3):215-22
8748390
Med Clin North Am. 1992 Mar;76(2):495-514
1312657
Arch Intern Med. 2002 Jun 10;162(11):1267-76
12038945
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1668-73
12496059
Psychopharmacology (Berl). 1998 Nov;140(1):98-104
9862408
Nicotine Tob Res. 2007 Jan;9(1):43-52
17365735
Lancet. 2001 May 19;357(9268):1571-5
11377644
Br J Gen Pract. 2005 Apr;55(513):305-12
15826439
Cancer Causes Control. 2005 May;16(4):347-58
15953977
JAMA. 1994 Feb 23;271(8):589-94
8301790
N Engl J Med. 1997 Oct 23;337(17):1195-202
9337378
Eur Respir J. 1999 Feb;13(2):238-46
10065662
Am J Prev Med. 2005 Nov;29(4):288-94
16242591
J Pharmacol Exp Ther. 2000 Oct;295(1):321-7
10991997
JAMA. 1995 Nov 1;274(17):1390-1
7563566
BMJ. 2004 Apr 10;328(7444):885-7
15073074
Nicotine Tob Res. 2009 Mar;11(3):234-9
19246427
Drug Alcohol Depend. 2007 Sep 6;90(1):56-63
17353101
JAMA. 1995 Nov 1;274(17):1353-8
7563559
Nicotine Tob Res. 2009 May;11(5):572-6
19351781
J Natl Cancer Inst. 2004 Jun 2;96(11):853-61
15173269
Drug Alcohol Depend. 1993 Jun;33(1):23-9
8370337
J Dent Res. 2005 Aug;84(8):705-10
16040726
Clin Pharmacol Ther. 1995 Mar;57(3):309-17
7697948
Cancer. 1995 May 15;75(10):2552-7
7736400
J Neurosci. 2005 Jun 29;25(26):6208-12
15987950
Mayo Clin Proc. 2003 Aug;78(8):1020-4; quiz 1024
12911050
Clin Pharmacokinet. 1996 Jul;31(1):65-80
8827400
Mayo Clin Proc. 2001 Feb;76(2):124-33
11213299
Clin Pharmacol Ther. 1997 Oct;62(4):453-63
9357397
J Clin Psychiatry. 1995 Sep;56(9):395-401
7665537
CA Cancer J Clin. 2005 Sep-Oct;55(5):281-99; quiz 322-3, 325
16166074
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004306
17943813
Arch Gen Psychiatry. 2006 Aug;63(8):907-15
16894067
J Gen Intern Med. 2009 Feb;24(2):149-54
19083066
Cancer Epidemiol Biomarkers Prev. 1997 Jan;6(1):15-9
8993792
Nicotine Tob Res. 2000 Feb;2(1):19-37
11072438
Mayo Clin Proc. 2007 Feb;82(2):186-95
17290726
J Cardiovasc Nurs. 2008 Sep-Oct;23(5):443-8
18728517
Clin Pharmacol Ther. 2009 Jun;85(6):635-43
19279561
Am J Epidemiol. 1986 Dec;124(6):926-41
3776975
JAMA. 2006 Jul 5;296(1):56-63
16820547
Head Neck Surg. 1986 Nov-Dec;9(2):104-10
3623935
NCI Monogr. 1989;(8):13-6
2654650
Nature. 1996 Jul 18;382(6588):255-7
8717040
JAMA. 2006 Jul 5;296(1):47-55
16820546
Clin Pharmacol Ther. 1993 Jul;54(1):98-106
8330471
Addiction. 1995 Dec;90(12):1671-82
8555958
J Neurosci. 2007 Feb 21;27(8):1964-72
17314292
Nicotine Tob Res. 2008 Feb;10(2):393-8
18236304
JAMA. 1994 Feb 23;271(8):595-600
8301791
JAMA. 1995 Nov 1;274(17):1347-52
7563558
J Pharmacol Exp Ther. 1999 Jan;288(1):88-92
9862757
Ann Intern Med. 2006 Dec 5;145(11):839-44
16954353
Nicotine Tob Res. 2007 Feb;9(2):233-40
17365754
Neuropharmacology. 2007 Mar;52(3):985-94
17157884
JAMA. 1990 Jul 11;264(2):218-24
2355443
Addict Behav. 2009 Jan;34(1):61-7
18814974
Ann Intern Med. 2009 Apr 7;150(7):447-54
19349630
J Gen Intern Med. 2009 May;24(5):563-9
19238488
J Pharmacol Exp Ther. 1999 Jun;289(3):1545-52
10336551
Am J Med Sci. 2003 Oct;326(4):206-11
14557736
Biochem Soc Symp. 1993;59:83-95
8192688
Am J Public Health. 1999 May;89(5):731-6
10224986